Latest Stories

Don’t miss our hot and upcoming stories
Is Aidoc’s $150M Bet on CARE™ and aiOS™ Resetting the Future of Clinical AI for 100 Million Patients?

Key Highlights CARE™ Foundation Model Redefining Standards in Clinical AIAidoc’s CARE™ model—now backed by $150…

ByByAnuja Singh Jul 31, 2025
Pfizer Secures Exclusive Global Rights to 3SBio’s Bispecific Antibody Targeting PD-1 and VEGF

Key Highlights A Bold Bet on BispecificsIn a significant expansion of its oncology pipeline, Pfizer…

ByByAnuja Singh Jul 29, 2025
Can AstraZeneca’s Imfinzi Redefine Gastric Cancer Treatment With FDA Priority Review Backing?

Key Highlights A New Chapter for Immunotherapy in Early-Stage GI CancersAstraZeneca’s Imfinzi is poised to…

ByByAnuja Singh Jul 29, 2025
Could GSK and Hengrui’s $12B Alliance Set a New Standard in China-Originated Drug Collaborations?

Key Highlights GSK Bets Big on Hengrui: A $12B Strategic Play Anchored in Respiratory InnovationIn…

ByByAnuja Singh Jul 29, 2025
Scroll to Top